The Benchmark Company Announces “Healthcare House Call” Upcoming Virtual 1x1 Investor Conference
June 11, 2020 16:34 ET
|
The Benchmark Company
NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company is pleased to announce our upcoming Virtual 1x1 “Healthcare House Call” Investor Conference June 15-16th. The conference features...
The Benchmark Company Announces Closing of Public Offering of $5.0 Million for Hoth Therapeutics, Inc.
May 28, 2020 10:02 ET
|
The Benchmark Company
NEW YORK, May 28, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company announced the closing on March 27th of an Underwritten Public Offering for Hoth Therapeutics, Inc. (NASDAQ: HOTH) of 1,818,182 shares...
The Benchmark Company Expands Its Biotechnology Focus With The Addition Of Dr. Aydin Huseynov And Dr. Okechukwu Linton
February 26, 2020 09:00 ET
|
The Benchmark Company, Llc
NEW YORK, Feb. 26, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC, an institutionally focused research, sales & trading, and investment banking firm covering multiple sectors, including...
The Benchmark Company Announces Closing of Public Offering of $5m for Seelos Therapeutics, Inc.
February 13, 2020 15:51 ET
|
The Benchmark Company, Llc
NEW YORK, Feb. 13, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company today announced the closing of an Underwritten Public Offering for Seelos Therapeutics, Inc. of 6,666,667 shares of common stock at...
Edward Rubin Joins the Benchmark Company as Co-Head of Investment Banking
December 02, 2019 09:37 ET
|
The Benchmark Company, Llc
NEW YORK, Dec. 02, 2019 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC, a leading investment bank focused on capital markets, equity research and sales & trading for emerging and growth...
The Benchmark Company, LLC Announces Closing of Initial Public Offering of CNS Pharmaceuticals, Inc.
November 13, 2019 16:30 ET
|
The Benchmark Company, Llc
NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC today announced the closing of an Initial Public Offering for CNS Pharmaceuticals, Inc. of 2,125,000 shares of common stock at...